Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 5, 2018 | Genomics | $32.1M Series B | Vertex | Lansdowne Partners, Oxford Science Enterprises, Tanarra Capital, Woodford Investment Management |
| Mar 16, 2017 | Kuur Therapeutics | $74.2M Series C | — | Touchstone Innovations, Woodford Investment Management |
| Nov 1, 2014 | Kuur Therapeutics | $79.0M Series B | — | Soffinova Partners, Imperial Innovations, Woodford Investment Management |
| Sep 12, 2013 | Plaxica | $12.7M Series C | Imperial Innovations | Nesta Impact Investments |
| Jul 23, 2012 | Kuur Therapeutics | $26.4M Other Equity | — | Cancer Prevention and Research Institute of Texas, Imperial Innovations |
| Jun 18, 2012 | Oxford Immunotec | $28.0M Other Equity | Susan Searle, Invesco Perpetual | Clarus, Draper Esprit, Kaiser Permanente Ventures, New Leaf Venture Partners, NTEC, Spark Ventures, The Dow Chemical Company, University of Oxford, Wellington Management |
| Sep 28, 2011 | Plaxica | $7.8M Series B | Imperial Innovations, Invesco Perpetual | Nesta |